A pharmaceutical company stopped using Microsoft's Copilot AI tool due to high cost and low value.
The company used Office 365 Copilot for 500 staff, and found it comparable to middle school presentations.
Microsoft is considering repackaging 365 licenses to better monetize AI features amid record capex.
That's exactly what happened when an IT executive at a pharmaceutical company tried out Microsoft's Copilot AI features.
The chief information officer of this pharma company paid extra to have 500 employees use Office 365 Copilot in the fourth quarter of 2023 and first quarter of 2024.
Persons:
—
Organizations:
Microsoft, Service, pharma, Business